Israel Englander’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $111M | Buy |
3,265,321
+1,371,476
| +72% | +$45.7M | 0.04% | 465 |
|
|
2026
Q1 | $57M | Buy |
+1,893,845
| New | +$60.9M | 0.02% | 753 |
|
|
2025
Q4 | – | Sell |
-1,067,974
| Closed | -$26.3M | – | 6458 |
|
|
2025
Q3 | $21.6M | Sell |
1,067,974
-31,120
| -3% | -$547K | 0.01% | 1585 |
|
|
2025
Q2 | $18.4M | Sell |
1,099,094
-4,396,395
| -80% | -$70.9M | 0.01% | 1655 |
|
|
2025
Q1 | $84.5M | Sell |
5,495,489
-1,046,700
| -16% | -$18.7M | 0.05% | 441 |
|
|
2024
Q4 | $144M | Sell |
6,542,189
-5,271,040
| -45% | -$95.9M | 0.07% | 253 |
|
|
2024
Q3 | $213M | Sell |
11,813,229
-314,948
| -3% | -$5.51M | 0.1% | 158 |
|
|
2024
Q2 | $197M | Buy |
12,128,177
+1,379,392
| +13% | +$21.2M | 0.09% | 191 |
|
|
2024
Q1 | $152M | Sell |
10,748,785
-4,322,067
| -29% | -$54.5M | 0.06% | 279 |
|
|
2023
Q4 | $157M | Buy |
15,070,852
+5,213,050
| +53% | +$48.7M | 0.07% | 254 |
|
|
2023
Q3 | $101M | Sell |
9,857,802
-4,172,267
| -30% | -$38.8M | 0.05% | 370 |
|
|
2023
Q2 | $106M | Buy |
14,030,069
+7,835,223
| +126% | +$63.5M | 0.05% | 343 |
|
|
2023
Q1 | $54.8M | Buy |
6,194,846
+5,158,012
| +497% | +$51M | 0.03% | 637 |
|
|
2022
Q4 | $9.46M | Sell |
1,036,834
-486,456
| -32% | -$4.24M | 0.01% | 2191 |
|
|
2022
Q3 | $12.3M | Sell |
1,523,290
-8,563,015
| -85% | -$75.7M | 0.01% | 1889 |
|
|
2022
Q2 | $75.8M | Sell |
10,086,305
-1,346,502
| -12% | -$11.7M | 0.05% | 422 |
|
|
2022
Q1 | $107M | Buy |
11,432,807
+8,752,890
| +327% | +$73M | 0.06% | 313 |
|
|
2021
Q4 | $21.5M | Buy |
2,679,917
+977,158
| +57% | +$8.82M | 0.01% | 1382 |
|
|
2021
Q3 | $16.6M | Buy |
1,702,759
+1,534,493
| +912% | +$14.4M | 0.01% | 1500 |
|
|
2021
Q2 | $1.67M | Sell |
168,266
-1,259,810
| -88% | -$13.3M | ﹤0.01% | 4174 |
|
|
2021
Q1 | $16.5M | Buy |
1,428,076
+1,081,801
| +312% | +$12.4M | 0.01% | 1265 |
|
|
2020
Q4 | $3.34M | Sell |
346,275
-730,775
| -68% | -$7M | ﹤0.01% | 2818 |
|
|
2020
Q3 | $9.7K | Buy |
1,077,050
+960,583
| +825% | +$10.2M | 0.01% | 1280 |
|
|
2020
Q2 | $1.44M | Sell |
116,467
-1,092,810
| -90% | -$12.4M | ﹤0.01% | 2763 |
|
|
2020
Q1 | $10.9M | Buy |
1,209,277
+409,411
| +51% | +$4.19M | 0.02% | 804 |
|
|
2019
Q4 | $7.84M | Sell |
799,866
-1,100,093
| -58% | -$9.82M | 0.01% | 1584 |
|
|
2019
Q3 | $13.1M | Buy |
1,899,959
+1,888,057
| +15,863% | +$14.5M | 0.02% | 1085 |
|
|
2019
Q2 | $110K | Sell |
11,902
-22,899
| -66% | -$276K | ﹤0.01% | 3876 |
|
|
2019
Q1 | $546K | Sell |
34,801
-528,918
| -94% | -$9.33M | ﹤0.01% | 3214 |
|
|
2018
Q4 | $8.69M | Sell |
563,719
-210,542
| -27% | -$4.32M | 0.01% | 1217 |
|
|
2018
Q3 | $16.7M | Sell |
774,261
-4,851,590
| -86% | -$113M | 0.02% | 939 |
|
|
2018
Q2 | $137M | Buy |
5,625,851
+5,549,041
| +7,224% | +$113M | 0.18% | 115 |
|
|
2018
Q1 | $1.31M | Sell |
76,810
-2,889,126
| -97% | -$56.4M | ﹤0.01% | 2553 |
|
|
2017
Q4 | $56.2M | Buy |
2,965,936
+1,071,583
| +57% | +$16.1M | 0.08% | 360 |
|
|
2017
Q3 | $33.3M | Buy |
1,894,353
+1,888,189
| +30,633% | +$42.5M | 0.05% | 507 |
|
|
2017
Q2 | $205K | Sell |
6,164
-1,468,824
| -100% | -$45.5M | ﹤0.01% | 3187 |
|
|
2017
Q1 | $47.3M | Buy |
1,474,988
+1,367,636
| +1,274% | +$46.7M | 0.09% | 327 |
|
|
2016
Q4 | $3.89M | Sell |
107,352
-1,646,808
| -94% | -$65.7M | 0.01% | 1496 |
|
|
2016
Q3 | $80.7M | Buy |
1,754,160
+558,417
| +47% | +$29.1M | 0.14% | 137 |
|
|
2016
Q2 | $60.1M | Buy |
1,195,743
+596,491
| +100% | +$31.8M | 0.14% | 158 |
|
|
2016
Q1 | $32.1M | Sell |
599,252
-2,401,067
| -80% | -$141M | 0.08% | 298 |
|
|
2015
Q4 | $197M | Buy |
3,000,319
+990,699
| +49% | +$61.2M | 0.41% | 26 |
|
|
2015
Q3 | $113M | Sell |
2,009,620
-297,710
| -13% | -$19.3M | 0.22% | 80 |
|
|
2015
Q2 | $136M | Sell |
2,307,330
-6,683,437
| -74% | -$412M | 0.26% | 62 |
|
|
2015
Q1 | $560M | Buy |
8,990,767
+3,697,503
| +70% | +$215M | 1.04% | 2 |
|
|
2014
Q4 | $304M | Buy |
5,293,264
+86,322
| +2% | +$4.81M | 0.65% | 3 |
|
|
2014
Q3 | $280M | Buy |
5,206,942
+1,182,407
| +29% | +$62.6M | 0.71% | 4 |
|
|
2014
Q2 | $211M | Sell |
4,024,535
-1,168,658
| -23% | -$59.7M | 0.58% | 9 |
|
|
2014
Q1 | $274M | Buy |
5,193,193
+2,326,853
| +81% | +$108M | 0.8% | 3 |
|
|
2013
Q4 | $115M | Buy |
2,866,340
+2,005,183
| +233% | +$79M | 0.36% | 23 |
|
|
2013
Q3 | $32.5M | Buy |
861,157
+553,476
| +180% | +$21.6M | 0.1% | 185 |
|
|
2013
Q2 | $12.1M | Buy |
+307,681
| New | +$12M | 0.04% | 533 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Israel Englander's TEVA Position: Q2 2026 in Review
Israel Englander increased its Teva Pharmaceuticals (TEVA) stake by 72% in Q2 2026, buying an estimated $45.7M and bringing the position to 3,265,321 shares worth $111M. The position accounts for 0.04% of the portfolio, ranked #465.
Israel Englander first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $560M in Q1 2015. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Israel Englander held 3,265,321 shares of Teva Pharmaceuticals worth $111M as of Q2 2026.
- Israel Englander bought 1,371,476 Teva Pharmaceuticals shares in Q2 2026, an estimated $45.7M.
- Teva Pharmaceuticals made up 0.04% of Israel Englander's portfolio in Q2 2026, its #465 holding.
- Israel Englander first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Israel Englander's Teva Pharmaceuticals position peaked at $560M in Q1 2015.
- 671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.